- Documentfimmu-11-01055uploaded byNandagopal Paneerselvam
- Documentfimmu-11-01022uploaded byNandagopal Paneerselvam
- DocumentPathophysiology,Transmission,Diagnosis,AndTreatment OfCoronavirusDisease2019(COVID-19) AReviewuploaded byNandagopal Paneerselvam
- Documentimmunotherapeutic strategiesuploaded byNandagopal Paneerselvam
- Document10.1007@s40495-020-00216-7uploaded byNandagopal Paneerselvam
- DocumentKinetics of Neutralizing Antibodies of COVID-19 Patients Tested Using Clinical D614G, B.1.1.7, and B 1.351 Isolates in Microneutralization Assays _ Enhanced Readeruploaded byNandagopal Paneerselvam
- DocumentSPIKE STIRUTREuploaded byNandagopal Paneerselvam
- DocumentSpike Stirutre2uploaded byNandagopal Paneerselvam
- DocumentSPIKE STIRUTRE1uploaded byNandagopal Paneerselvam
- DocumentSPIKE STIRUTRE3uploaded byNandagopal Paneerselvam
- Documentpathogens-10-00153-v2uploaded byNandagopal Paneerselvam
- DocumentEstablishment and Validation of a Pseudovirus Neutralization Assayuploaded byNandagopal Paneerselvam
- Document2020 Assessing SARS COVID-2 Neutralization Assayuploaded byNandagopal Paneerselvam
- DocumentPegu Et Al. - 2021 - Durability of MRNA-1273-Induced Antibodies Againstuploaded byNandagopal Paneerselvam
- Documentvaccines-09-00013uploaded byNandagopal Paneerselvam
- Documentmainuploaded byNandagopal Paneerselvam